end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccruedLiabilitiesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AllocatedShareBasedCompensationExpense,AllowanceForDoubtfulAccountsReceivable,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosureRecurring,AvailableForSaleSecurities,AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleSecuritiesAmortizedCost,AvailableForSaleSecuritiesDebtSecuritiesCurrent,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,AvailableForSaleSecuritiesGrossRealizedGainLossNet,BusinessAcquisitionsProFormaNetIncomeLoss,BusinessAcquisitionsProFormaRevenue,CapitalExpendituresIncurredButNotYetPaid,CapitalLeaseObligationsNoncurrent,CapitalLeasesFutureMinimumPaymentsDueCurrent,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightOutstanding,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockDividendsPerShareDeclared,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractualObligation,ContractualObligationDueInFifthYear,ContractualObligationDueInFourthYear,ContractualObligationDueInNextTwelveMonths,ContractualObligationDueInSecondYear,ContractualObligationDueInThirdYear,ContractWithCustomerAssetNet,ContractWithCustomerLiability,ContractWithCustomerLiabilityCurrent,ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination,ConversionOfStockAmountConverted1,ConvertiblePreferredStockSharesIssuedUponConversion,CostOfGoodsAndServicesSold,CostOfGoodsSold,CurrentIncomeTaxExpenseBenefit,DeferredFederalIncomeTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredIncomeTaxLiabilities,DeferredIncomeTaxLiabilitiesNet,DeferredOfferingCosts,DeferredRentCreditCurrent,DeferredStateAndLocalIncomeTaxExpenseBenefit,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,DeferredTaxLiabilitiesNoncurrent,DefinedContributionPlanAdministrativeExpenses,DefinedContributionPlanCostRecognized,DepreciationDepletionAndAmortization,DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage,DividendsPreferredStock,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,EffectOfExchangeRateOnCashContinuingOperations,EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount,EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,EquityMethodInvestments,EquitySecuritiesFvNiGainLoss,ExcessStockSharesAuthorized,FairValueAdjustmentOfWarrants,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings,FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue,FinanceLeaseInterestExpense,FinanceLeaseLiability,FinanceLeaseLiabilityCurrent,FinanceLeaseLiabilityNoncurrent,FinanceLeaseLiabilityPaymentsDue,FinanceLeaseLiabilityPaymentsDueNextTwelveMonths,FinanceLeaseLiabilityPaymentsDueYearThree,FinanceLeaseLiabilityPaymentsDueYearTwo,FinanceLeaseLiabilityUndiscountedExcessAmount,FinanceLeasePrincipalPayments,FinanceLeaseRightOfUseAssetAmortization,FinanceLeaseWeightedAverageDiscountRatePercent,ForeignCurrencyTransactionGainLossBeforeTax,ForeignIncomeTaxExpenseBenefitContinuingOperations,GainLossOnDispositionOfIntangibleAssets,GeneralAndAdministrativeExpense,Goodwill,GoodwillAndIntangibleAssetImpairment,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxExpenseBenefit,IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccountsReceivableRelatedParties,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInDeferredIncomeTaxes,IncreaseDecreaseInDeferredLiabilities,IncreaseDecreaseInInventories,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncreaseDecreaseInRestrictedCash,IncreaseInRestrictedCash,IncrementalCommonSharesAttributableToCallOptionsAndWarrants,IntangibleAssetsNetExcludingGoodwill,InterestAndDividendIncomeOperating,InterestExpense,InventoryFinishedGoods,InventoryNet,InventoryWorkInProcess,InvestmentIncomeInterest,InvestmentIncomeNetAmortizationOfDiscountAndPremium,InvestmentsFairValueDisclosure,LeaseAndRentalExpense,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesFairValueDisclosureRecurring,LongTermInvestments,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInFinancingActivitiesContinuingOperations,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInInvestingActivitiesContinuingOperations,NetCashProvidedByUsedInOperatingActivities,NetCashProvidedByUsedInOperatingActivitiesContinuingOperations,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NonoperatingIncomeExpense,NumberOfReportableSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFiveYears,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesRentExpenseNet,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax,OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax,OtherComprehensiveIncomeLossNetOfTax,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherLiabilitiesNoncurrent,OtherNoncashIncomeExpense,OtherNonoperatingExpense,OtherNonoperatingIncomeExpense,PaidInKindInterest,PaymentsForProceedsFromOtherInvestingActivities,PaymentsForTenantImprovements,PaymentsForUnderwritingExpense,PaymentsOfDividends,PaymentsOfDividendsPreferredStockAndPreferenceStock,PaymentsToAcquireAvailableForSaleSecurities,PaymentsToAcquireAvailableForSaleSecuritiesDebt,PaymentsToAcquireBusinessesNetOfCashAcquired,PaymentsToAcquireEquityMethodInvestments,PaymentsToAcquireIntangibleAssets,PaymentsToAcquireInvestments,PaymentsToAcquireNotesReceivable,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockAccretionOfRedemptionDiscount,PreferredStockAmountOfPreferredDividendsInArrears,PreferredStockDividendsAndOtherAdjustments,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromPaymentsForOtherFinancingActivities,ProceedsFromRepaymentsOfNotesPayable,ProceedsFromRoyaltiesReceived,ProceedsFromSaleOfAvailableForSaleSecurities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,ProceedsFromSaleOfIntangibleAssets,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,PurchaseObligation,RepaymentsOfNotesPayable,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalents,RestrictedCashAndCashEquivalentsAtCarryingValue,RestrictedCashAndCashEquivalentsNoncurrent,RestrictedCashCurrent,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerExcludingAssessedTax,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,SaleOfStockNumberOfSharesIssuedInTransaction,SaleOfStockPricePerShare,SalesRevenueGoodsNet,SalesRevenueNet,SellingGeneralAndAdministrativeExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions,ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1,ShortTermInvestments,ShortTermLeaseCost,StateAndLocalIncomeTaxExpenseBenefitContinuingOperations,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueOther,StockIssuedDuringPeriodValueStockOptionsExercised,UndistributedEarningsOfForeignSubsidiaries,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions,ValuationAllowanceDeferredTaxAssetChangeInAmount,VariableLeaseCost,WarrantsNotSettleableInCashFairValueDisclosure,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation,WeightedAverageNumberOfSharesOutstandingBasic,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleSecuritiesDebtSecurities,DeferredTaxAssetsEquityMethodInvestments
2013-12-31,2014-03-24,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,1437000.0,,-1413000.0,4406000.0,797000.0,,,11000.0,,,,,,657000.0,,21819014.0,59649000.0,55225000.0,52797000.0,52797000.0,17000.0,6000.0,52786000.0,,,,,,,,,7427000.0,-78763000.0,,,,,22980791.0,,0.001,250000000.0,31934682.0,3766289.0,4000.0,-35059000.0,,,,,,,,,,,,,,,,,,,,,78000.0,,25700000.0,,0.0,16352000.0,,8692000.0,591000.0,25700000.0,,,,,444000.0,,,,-19.85,,,0.34,0.446,,,,0.029,0.006,,0.05,0.082,,,,2360000.0,,200000.0,,,,,2901000.0,2901000.0,3419000.0,,,,,,,,,,,,,,,,4451000.0,,,,,,0.0,,237000.0,,,2426000.0,,,,2615000.0,,1593000.0,-25000.0,,,,,,,,,216000.0,,,,,,,,,,,,,,9540000.0,59649000.0,5921000.0,3419000.0,,,171000.0,,-47734000.0,,-31200000.0,-46387000.0,-68954000.0,-2790000.0,,41805000.0,-32280000.0,,,,,,,,,,,,,,300000.0,,160000.0,2648000.0,,,,11000.0,200000.0,,,-3006000.0,,,,,,,63953000.0,,,,,,,407000.0,13543000.0,4000000.0,15219000.0,0.001,25000000.0,0.0,0.0,1848000.0,171000.0,,,,16601000.0,,,,,,,,,2122000.0,1325000.0,,,27829000.0,,,451000.0,,,-74836000.0,,,,,,,,657000.0,0.0,0.74,,0.016,0.007,,,1000000.0,252515.0,1267797.0,3.82,19468000.0,2228883.0,3.41,,,,,0.55,1.26,5.8,,,,100000.0,,45950000.0,,,-74821000.0,,307366.0,,,,171000.0,,3725000.0,5000.0,,,2169000.0,,15600000.0,,3400000.0,,3382489.0,201033.0,3583522.0,,,,,
2014-03-31,2014-05-12,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,3495000.0,,-479000.0,3238000.0,,,,-46000.0,258599000.0,,,,6743000.0,795000.0,,9201632.0,172707000.0,169636000.0,161056000.0,161056000.0,,,161102000.0,,,0.0,,,,,,55447000.0,48020000.0,,,,,,,0.001,250000000.0,30049650.0,30049650.0,30000.0,-13687000.0,,,,,,,,,,,129360000.0,,,,,,,,,,78000.0,,,,,,,,,,,,,,117000.0,,,,-0.85,,,,,,,,,,,,,,,6743000.0,1557000.0,,,,,,275000000.0,3324000.0,3324000.0,,,,,,,,,,,,,,,,,1986000.0,,,,,,,,2058000.0,,,-1186000.0,,,,187000.0,-2098000.0,2391000.0,293000.0,,,,93000.0,,,,,93000.0,-479000.0,,,,,,,,,,,,,6993000.0,172707000.0,6811000.0,,,121754000.0,124039000.0,-65398000.0,-65398000.0,-8336000.0,-10621000.0,-13630000.0,-18438000.0,-3291000.0,,10339000.0,-10339000.0,,,,,,,,,,,,,,,,309000.0,550000.0,,,,-57000.0,182000.0,,3384000.0,-3384000.0,,,,,4346000.0,4346000.0,87998000.0,,,,,87998000.0,,569000.0,,,4808000.0,0.001,25000000.0,,,4239000.0,128385000.0,,,,23462000.0,,,,,,,,,,1777000.0,850000.0,,8353000.0,,,744000.0,,,-92869000.0,,,,,,,,795000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,109950000.0,,,165714000.0,,,,,,,,,,,,,,,,,,21582435.0,,21582435.0,,,,,
2014-06-30,2014-08-11,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,3590000.0,,,5278000.0,,,,-48000.0,259555000.0,,,,,946000.0,,2914816.0,162586000.0,158216000.0,143583000.0,143583000.0,,,143631000.0,,,,,,,,,17452000.0,,,,,,,,0.001,250000000.0,30059288.0,30059288.0,30000.0,-13587000.0,,,,,,,,,,,,,,,,,,,,,75000.0,,,,,,,,,,,,,,,,,,-0.45,,,,,,,,,,,,,,,,2208000.0,,,,,,275000000.0,,,,,,,,,,,,,,,,,,,2422000.0,,,,,,,,,,,,,,,,,,,,,,149000.0,,,,,149000.0,,,,,,,,,,,,,,9503000.0,162586000.0,8943000.0,,,,,,,,,-13585000.0,-13585000.0,76000.0,,13661000.0,-13661000.0,,,,,,,,,,,,,,,,218000.0,1129000.0,,,,-2000.0,560000.0,,73000.0,-73000.0,,,,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,4945000.0,,,,,,,,,,,,,,,2497000.0,780000.0,,11239000.0,,,744000.0,,,-106454000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,135819000.0,,,153083000.0,,,,,,,,,,,,,,,,,,30055943.0,,30055943.0,,,,,
2014-09-30,2014-11-10,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,4161000.0,,,6831000.0,,,,-118000.0,321714000.0,,,,,1652000.0,,3115114.0,210931000.0,206741000.0,194939000.0,194939000.0,,,195057000.0,,,,,,,,,53387000.0,,,,,,,,0.001,250000000.0,31846472.0,31846472.0,32000.0,-15919000.0,,,,,,,,,,,,,,,,,,,,,80000.0,,,,,,,,,,,,,,,,,,-0.5,,,,,,,,,,,,,,,,2974000.0,,,,,,275000000.0,,,,,,,,,,,,,,,,,,,2981000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,171000.0,,,,,,,,,,,,,,11605000.0,210931000.0,11072000.0,,,,,,,,,-15849000.0,-15849000.0,-14000.0,,15835000.0,-15835000.0,,,,,,,,,,,,,,,,505000.0,825000.0,,,,-70000.0,533000.0,,,-185000.0,,,,,,,,,,,,,,,,,,0.001,25000000.0,0.0,0.0,5547000.0,,,,,,,,,,,,,,,2621000.0,479000.0,,12854000.0,,,744000.0,,,-122302000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,147807000.0,,,199326000.0,,,,,,,,,,,,,,,,,,31631385.0,,31631385.0,,,,,
2014-12-31,2015-03-27,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,4857000.0,,-3600000.0,7575000.0,1481000.0,,,-174000.0,324128000.0,6743000.0,,5394000.0,,5394000.0,,4540995.0,197967000.0,193416000.0,175805000.0,175805000.0,6000.0,180000.0,175979000.0,,,0.0,,,243000.0,,1173000.0,24324000.0,16897000.0,,,,324351.0,5134576.0,0.0,0.001,250000000.0,31934682.0,31934682.0,32000.0,-59987000.0,,,,,,,,,,,129360000.0,,,,,,,,,,85000.0,,51339000.0,,0.0,32500000.0,113000.0,16737000.0,476000.0,51339000.0,,,,,684000.0,119400000.0,,,-2.77,,,0.34,0.427,,,,-0.012,-0.014,,0.046,-0.067,,,6743000.0,4205000.0,,700000.0,22500000.0,,,,3324000.0,3324000.0,,,,,,,,,,,,,,,,,10811000.0,,,-59802000.0,-59802000.0,,0.0,,3177000.0,,,3481000.0,,,,411000.0,,4081000.0,293000.0,293000.0,,,,,,,,608000.0,,,,,,,,,,,,,,13022000.0,197967000.0,12517000.0,,,,184971000.0,,-123440000.0,,-44634000.0,-76540000.0,-81348000.0,-3024000.0,,73721000.0,-56778000.0,,,,,,,5739000.0,,560000.0,1366000.0,1335000.0,1305000.0,,600000.0,,545000.0,774000.0,,,-185000.0,-185000.0,505000.0,,,-3632000.0,,,,,,4346000.0,208972000.0,,,,,,,2149000.0,4430000.0,,4808000.0,0.001,25000000.0,,0.0,5929000.0,188581000.0,,,736000.0,82972000.0,,,,5002000.0,,,,,4514000.0,3033000.0,,,45967000.0,594000.0,,744000.0,,,-139041000.0,,,,,,,,5394000.0,0.0,0.7,0.019,,,802189.0,2.65,12100000.0,116873.0,932555.0,26.58,79840000.0,2739475.0,16.15,33072000.0,78390000.0,2666378.0,15.86,2.14,8.92,41.12,802189.0,2739475.0,,2000000.0,2.65,163163000.0,,,184945000.0,,305090.0,129360000.0,121711000.0,,736000.0,,7275000.0,,0.0,,3550000.0,,25600000.0,,,,28755758.0,,28755758.0,,,,,
2015-03-31,2015-05-12,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,5755000.0,,-965000.0,8398000.0,,,,-94000.0,501597000.0,,,,,2408000.0,,3057053.0,355840000.0,350514000.0,328296000.0,328296000.0,14000.0,108000.0,328390000.0,,,0.0,,,,,,178040000.0,153716000.0,,,,,,,0.001,250000000.0,35612019.0,35612019.0,36000.0,-21299000.0,,,,,,,,,,,,,,,,,,,,,90000.0,,,,,,,,,,,,123000.0,,201000.0,,,,-0.63,,,,,,,,,,,,,,,,3217000.0,,,,,,,0.0,,,,,,,,,,,,,,,,,,4138000.0,,,,,,,,437000.0,,,664000.0,,,,7000.0,,948000.0,1358000.0,1358000.0,,,,,,,,273000.0,,,,,,,,,,,,,,14721000.0,355840000.0,14243000.0,,,,175440000.0,,-4065000.0,,-17659000.0,-21379000.0,-21379000.0,123000.0,,21502000.0,-21502000.0,,,,,,,,,,,,,,,,910000.0,781000.0,,,,80000.0,478000.0,,,-150000.0,,,,,,,77254000.0,,,,,,,459000.0,,,,0.001,25000000.0,,0.0,6877000.0,175440000.0,,,,62240000.0,,,,12766000.0,,,,,,3514000.0,,,17364000.0,,1071000.0,1031000.0,,,-160420000.0,,,,,,,,2408000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,164526000.0,,,341119000.0,,,,,,,,,,,0.0,,,,,,,34008830.0,,34008830.0,,,,,
2015-06-30,2015-08-14,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,10171000.0,,,12716000.0,,,,-209000.0,509658000.0,,,,,5091000.0,,3226559.0,343004000.0,336530000.0,307811000.0,307811000.0,19000.0,228000.0,308020000.0,,,,,,,,,52351000.0,,,,,149700.0,,,0.001,250000000.0,36071596.0,36071596.0,36000.0,-29902000.0,,,,,,,,,,,,,,,,,,,,,155000.0,,,,,,,,,,,,,149000.0,,,,,-0.83,,,,,,,,,,,,,,,,4972000.0,,,,,,,,,,,,,,,,,,,,,,,,,7038000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,456000.0,,,,,,,,,,,,,,23726000.0,343004000.0,23042000.0,,,,,,,,,-29787000.0,-29787000.0,355000.0,,30142000.0,-30142000.0,,,,,,,,,,,,,,,,2030000.0,790000.0,,,-115000.0,-115000.0,684000.0,,,-101000.0,,,,,,,,,,,,,,,,,,0.001,25000000.0,,0.0,9430000.0,,,,,,,,,,,,,,,4772000.0,,,23104000.0,,1071000.0,912000.0,,,-190207000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,273678000.0,,,319278000.0,,,,,,,,,,,,,,,,,,35937442.0,,35937442.0,,,,,
2015-09-30,2015-11-10,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,4422000.0,,,20148000.0,,,,-39000.0,806202000.0,,,,,7896000.0,,3838480.0,602130000.0,460707000.0,570004000.0,570004000.0,157000.0,196000.0,570043000.0,,,,,,,,,166686000.0,,,,,149700.0,,,0.001,250000000.0,38822177.0,38822177.0,39000.0,-39062000.0,,,,,,,,,,,,,,,,,,,,,163000.0,,,,,,,,,,,,,200000.0,,,,,-1.03,,,,,,,,,,,,,,,,7668000.0,,,,,,,,,,,,,,,,,,,,,,,,,10232000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,673000.0,,,,,,,,,,,,,,25367000.0,602130000.0,24733000.0,,133492000.0,,,,,,,-39232000.0,-39232000.0,704000.0,,39936000.0,-39936000.0,,,,,,,,,,,,,,,,3652000.0,734000.0,,,170000.0,170000.0,634000.0,,,31000.0,,,,,,,,,,,,,,,,,,0.001,25000000.0,,0.0,12324000.0,,,,,,,,,,,,,,,6285000.0,,,29704000.0,,,912000.0,,,-229439000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,281697000.0,,,576763000.0,,,,,,,,,,,,,,,,,,38268632.0,,,,,,,
2015-12-31,2016-02-26,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,2942000.0,,-5637000.0,24784000.0,2865000.0,,,-868000.0,816578000.0,,-918000.0,24884000.0,,24884000.0,,3564269.0,559569000.0,450207000.0,514340000.0,514340000.0,11000.0,879000.0,515208000.0,,,0.0,,,769000.0,,,93569000.0,69245000.0,,95854000.0,,149700.0,5834075.0,0.0,0.001,250000000.0,38882394.0,38882394.0,39000.0,-146312000.0,2467000.0,62000.0,83000.0,2042000.0,190000.0,90000.0,,,,,,,,,,,,,,,192000.0,,109479000.0,,0.0,61503000.0,432000.0,33881000.0,2541000.0,109479000.0,,,,600000.0,1384000.0,,,,-5.38,,,0.34,-0.392,,,,,-0.013,0.008,0.075,-0.059,,,,9423000.0,,6900000.0,102800000.0,,,,0.0,,,,,,,,,,,,,,,,,,33001000.0,,,-145618000.0,-145618000.0,,0.0,,-1982000.0,,,16670000.0,,,,-179000.0,,7131000.0,1541000.0,1541000.0,,,,,,,,2320000.0,,,,,,,,,,,,,,28479000.0,559569000.0,27918000.0,,99259000.0,,467573000.0,,-292351000.0,,-105977000.0,-200838000.0,-200838000.0,2120000.0,,203896000.0,-147738000.0,,,,,,,30853000.0,2270000.0,2868000.0,3543000.0,4504000.0,3877000.0,13791000.0,1400000.0,,5597000.0,595000.0,,,-694000.0,-694000.0,561000.0,,,-200000.0,,,,,,,624226000.0,,,,,,,4955000.0,,,,0.001,25000000.0,,0.0,13060000.0,461136000.0,,,6437000.0,249050000.0,,,,89321000.0,,,6900000.0,,10238000.0,7373000.0,,,114737000.0,,150000.0,2135000.0,,,-284659000.0,,,,,,,33001000.0,24884000.0,0.0,0.65,0.018,,,898924.0,13.3,59000000.0,130037.0,2013350.0,54.9,217386000.0,3826963.0,56.36,88886000.0,212968000.0,3681683.0,55.27,8.65,31.49,90.6,898924.0,3826963.0,2900000.0,10700000.0,13.3,343428000.0,,,531090000.0,,795825.0,,,,7355000.0,,24010000.0,4398000.0,0.0,0.0,15628000.0,5505000.0,58100000.0,,,,36782603.0,,36782603.0,,,,,
2016-03-31,2016-05-10,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,6012000.0,,-1828000.0,23565000.0,,,,92000.0,827109000.0,,,,,10217000.0,,4190773.0,524184000.0,430234000.0,472908000.0,472908000.0,244000.0,152000.0,472816000.0,,,0.0,,,,,,70763000.0,-22806000.0,,,,,,,,250000000.0,38992346.0,38992346.0,39000.0,-51797000.0,,,,,,,,,,,,,,,,,,,,,303000.0,,,,,,,,,,,,,,544000.0,,,,-1.35,,,,,,,,,,,,,,,,5339000.0,,,,,,,,,,,,,,,,,,,,,,,,,13207000.0,,,,,,,,2638000.0,,,-1869000.0,,,,1468000.0,,4028000.0,1543000.0,1543000.0,,,,,,,,984000.0,,,,,,,,,,,,,,34360000.0,524184000.0,29880000.0,,75932000.0,,314000.0,,21775000.0,,-44895000.0,-52757000.0,-52757000.0,865000.0,1.0,53622000.0,-53622000.0,,,,,,,,,,,,,,,,5047000.0,2063000.0,,,960000.0,960000.0,4480000.0,,,-119000.0,,,,,,,118130000.0,,,,,,,1477000.0,,,,,25000000.0,,0.0,17088000.0,314000.0,,,314000.0,131431000.0,,,,11494000.0,,,,,,13418000.0,,,40415000.0,,1291000.0,2537000.0,,,-337416000.0,,,,,,,,10217000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,341092000.0,,,489824000.0,,,,,,,,,,,,,,,,,,38970151.0,,,,,,,
2016-06-30,2016-08-09,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,6954000.0,,,24714000.0,,,,252000.0,837943000.0,,,,,10860000.0,,4639575.0,481951000.0,411084000.0,427339000.0,427339000.0,288000.0,49000.0,427100000.0,,,,,,,,,55069000.0,,,,,,,,,250000000.0,39046247.0,39046247.0,39000.0,-56763000.0,,,,,,,,,,,,,,,,,,,,,315000.0,,,,,,,,,,,,,,,,,,-1.46,,,,,,,,,,,,,,,,8980000.0,,,,,,,,,,,,,,,,,,,,,,,,,14738000.0,,,,-56923000.0,,,,,,,,,,,,,,,,,,,,,,,971000.0,,,,,,,,,,,,,,38056000.0,481951000.0,31983000.0,,50021000.0,,,,,,,-56923000.0,-56923000.0,1130000.0,,58070000.0,-58053000.0,,,,,,,,,,,,,,,,4612000.0,1446000.0,11000.0,,160000.0,149000.0,6073000.0,,,159000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,17799000.0,,,,,,,,,,,,,,,17054000.0,,,43332000.0,,1482000.0,2346000.0,,,-394339000.0,,,,,17000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,336734000.0,,,443895000.0,,,,,,,,,,,,,,,,,,39028701.0,,,,,,,
2016-09-30,2016-11-08,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,6616000.0,,,43487000.0,,,,12000.0,915084000.0,,,,,13694000.0,,5345897.0,515166000.0,416785000.0,451030000.0,451030000.0,143000.0,114000.0,451001000.0,,,,,,,,,142280000.0,,,,,,,,,250000000.0,40052032.0,40052032.0,40000.0,-65147000.0,,,,,,,,,,,,,,,,,,,,,328000.0,,,,,,,,,,,,,,,,,,-1.64,,,,,,,,,,,,,,,,11818000.0,,,,,,,,,,,,,,,,,,,,,,,,,17183000.0,,,,-64907000.0,,,,,,,,,,,,,,,,,,,,,,,922000.0,,,,,,,,,,,,,,59276000.0,515166000.0,50431000.0,,76211000.0,,,,,,,-64907000.0,-64907000.0,876000.0,,65894000.0,-65783000.0,,,,,,,,,,,,,,,,4030000.0,1868000.0,-28000.0,,-240000.0,-212000.0,8845000.0,,,-46000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,18944000.0,,,,,,,,,,,,,,,18226000.0,,,48711000.0,,1411000.0,2076000.0,,,-459246000.0,,,,,111000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,254150000.0,,,455890000.0,,,,,,,,,,,,,,,,,,39551923.0,,,,,,,
2016-12-31,2017-02-17,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,5364000.0,,-4842000.0,54554000.0,6161000.0,-417000.0,1322000.0,905000.0,1003561000.0,,-1262000.0,48309000.0,,48309000.0,,4856744.0,540626000.0,401695000.0,482876000.0,482876000.0,27000.0,444000.0,483293000.0,,,0.0,306596000.0,12684000.0,147000.0,,,161120000.0,67551000.0,164607000.0,164607000.0,68753000.0,,,,0.001,250000000.0,41240230.0,41240230.0,41000.0,-244101000.0,3093000.0,,62000.0,1956000.0,810000.0,265000.0,,,,,,,,,35000.0,,,,,,341000.0,,212371000.0,,0.0,102960000.0,1950000.0,78324000.0,10039000.0,212371000.0,,,,1500000.0,3424000.0,,,,-7.96,,0.0,0.34,-0.419,,,-0.074,,-0.014,-0.003,0.013,-0.137,-65000.0,-65000.0,,17226000.0,0.0,9000000.0,136500000.0,,,,0.0,,,,,,,,,,,,,,,-1322000.0,35000.0,,64936000.0,,,-192287000.0,-245839000.0,-53552000.0,35000.0,,2502000.0,,,32189000.0,,,,1242000.0,,7147000.0,1202000.0,1202000.0,,,,,,,,3789000.0,,,,,,,,,,,,,,66652000.0,540626000.0,60259000.0,,117963000.0,138676000.0,138676000.0,91117000.0,89915000.0,-160975000.0,-160975000.0,-317161000.0,-317161000.0,2168000.0,,318694000.0,-248007000.0,,,,,,,28702000.0,3956000.0,2346000.0,2867000.0,3553000.0,4534000.0,11446000.0,3300000.0,,5085000.0,1837000.0,1322000.0,,1773000.0,451000.0,6393000.0,-700000.0,,-1621000.0,,,3467000.0,,,,442490000.0,,,,,,,10188000.0,,,,0.001,25000000.0,,0.0,20136000.0,,,51356000.0,7834000.0,403239000.0,,,,140556000.0,,,9000000.0,-245874000.0,23216000.0,17055000.0,,,183204000.0,,1411000.0,2076000.0,1411000.0,2076000.0,-530533000.0,133000.0,,,,138000.0,133000.0,64936000.0,48309000.0,,,,,,1620443.0,44.96,22200000.0,407564.0,1435995.0,40.49,79135000.0,4429472.0,61.85,55537000.0,78412000.0,4264788.0,61.33,21.21,70.87,67.0,,,,43800000.0,,219028000.0,,,473974000.0,,425922.0,,,,9096000.0,100000.0,13505000.0,18159000.0,0.0,0.0,6777000.0,877000.0,102900000.0,,,,39586908.0,,,,,,,
2017-03-31,2017-05-05,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,8345000.0,,549000.0,42773000.0,,,,231000.0,1087028000.0,,,,,14499000.0,,5478008.0,545822000.0,444685000.0,497978000.0,497978000.0,29000.0,472000.0,498421000.0,,,0.0,,,,,,159501000.0,-1619000.0,161768000.0,,-2839000.0,,,,,250000000.0,42273429.0,42273429.0,42000.0,-68964000.0,,,,,,,,,,,,,,,,,,,,,637000.0,,,,,,,,,,,,,,1161000.0,,,-1.63,-1.63,-1.63,,,,,,,,,,,,,17000.0,,10514000.0,,,,,,,,,,,,,,,,,,,,,,648000.0,,,18685000.0,,,,-68290000.0,,,,2989000.0,,,-12470000.0,,,,-75000.0,,-930000.0,-1220000.0,,,,,,,,,1082000.0,,,,,,,,,,,,,,57344000.0,545822000.0,51755000.0,,80862000.0,,68969000.0,,-10620000.0,,-61205000.0,-68290000.0,,1664000.0,,69954000.0,-69954000.0,,,,,,,,,,,,,,,,4737000.0,1762000.0,-648000.0,,-674000.0,-26000.0,5589000.0,,,582000.0,,,,,,,87527000.0,,,,,,,485000.0,,,,,25000000.0,,0.0,19224000.0,,,,1378000.0,64977000.0,,,,12415000.0,,,,,,16517000.0,,,51269000.0,,271000.0,1996000.0,,,-598823000.0,,,,,,,18685000.0,14499000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,265689000.0,,,488478000.0,,,,,,,,,,,,,,,,,41841612.0,41841612.0,,41841612.0,,,,,
2017-06-30,2017-07-28,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,11876000.0,,,50130000.0,,-494000.0,-3729000.0,-4223000.0,1105348000.0,,,,,16794000.0,,5924120.0,497542000.0,419794000.0,442655000.0,442655000.0,13000.0,507000.0,443149000.0,,,,,,,,,90751000.0,,93017000.0,,,,,,,250000000.0,42428124.0,42428124.0,42000.0,-77345000.0,,,,,,,,,,,,,,,,,,,,,669000.0,,,,,,,,,,,,,,,,,,-1.72,,,,,,,,,,,,,,,,15396000.0,,,,,,,,,,,,,,,,,,,,,,,,,20005000.0,,,,-72877000.0,,14000.0,,,,,,,,,,,,,,,,,,,,,1151000.0,,,,,,,,,,,,,,68089000.0,497542000.0,62675000.0,,57802000.0,,,,,,,-72891000.0,,5564000.0,,78441000.0,-78441000.0,,,,,,,,,,,,,,,,6068000.0,1736000.0,-4403000.0,,-4454000.0,-51000.0,5414000.0,,,4413000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,19685000.0,,,,,,,,,,,,,,,16405000.0,,,58436000.0,,461000.0,1805000.0,,,-671714000.0,,,,,,,20005000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,308897000.0,,,429453000.0,,,,,,,,,,,,,,,,,,42346830.0,,,,,,,
2017-09-30,2017-11-03,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,9288000.0,,,54278000.0,,-349000.0,-7055000.0,-7404000.0,1123861000.0,,,,,17180000.0,,6016985.0,435047000.0,390903000.0,377851000.0,377851000.0,9000.0,358000.0,378200000.0,,,,,,,,,60407000.0,,,62673000.0,,,,,,250000000.0,42488312.0,42488312.0,42000.0,-82408000.0,,,,,,,,,,,,,,,,,,,,,695000.0,,,,,,,,,,,,,,,,,,-1.87,,,,,,,,,,,,,,,,19102000.0,,,,,,,,,,,,,,,,,,,,,,,,,23499000.0,,,,-79223000.0,,4000.0,,,,,,,,,,,,,,,,,,,,,1117000.0,,,,,,,,,,,,,,69489000.0,435047000.0,64261000.0,,24964000.0,,,,,,,-79227000.0,,4490000.0,,83911000.0,-83713000.0,,,,,,,,,,,,,,,,6646000.0,1345000.0,-3326000.0,,-3181000.0,145000.0,5228000.0,,,3373000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,19376000.0,,,,,,,,,,,,,,,16030000.0,,,60412000.0,,461000.0,1805000.0,461000.0,1805000.0,-750941000.0,198000.0,,,,198000.0,,23499000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,310659000.0,,,365558000.0,,,,,,,,,,,,,,,,,,42471606.0,,,,,,,
2017-12-31,2018-02-21,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,8886000.0,5172000.0,-1706000.0,62128000.0,10991000.0,-382000.0,-5298000.0,-5680000.0,1221762000.0,,,68014000.0,,68014000.0,,6015212.0,490753000.0,269583000.0,223649000.0,223649000.0,,382000.0,224031000.0,,,0.0,341700000.0,18500000.0,400000.0,,,100488000.0,-60632000.0,103041000.0,103041000.0,-61566000.0,,,,0.001,250000000.0,44167071.0,44167071.0,44000.0,-308724000.0,8828000.0,,,7542000.0,1224000.0,62000.0,,5986000.0,5986000.0,2526000.0,,,1000.0,1000.0,47000.0,-16243000.0,-16246000.0,,,,701000.0,-3000.0,304246000.0,31166000.0,,154949000.0,1286000.0,119542000.0,5939000.0,304246000.0,,31166000.0,,2100000.0,5825000.0,,,,-9.01,,0.051,0.34,-0.325,0.051,,-0.072,,-0.006,-0.009,,-0.09,528000.0,528000.0,,26527000.0,0.0,,165300000.0,,,,,,,,,,,,,,,,,,,7018000.0,42000.0,,,44406000.0,,-250917000.0,-318338000.0,-67421000.0,-16199000.0,70500000.0,3459000.0,5172000.0,,-4628000.0,-16200000.0,-16246000.0,757000.0,-522000.0,,-3113000.0,-934000.0,,,141545000.0,,,20000.0,757000.0,737000.0,4074000.0,,,4500000.0,,,,,,,,,,,107299000.0,490753000.0,71014000.0,,9975000.0,136267000.0,136267000.0,55482000.0,56416000.0,-253843000.0,-253843000.0,-383870000.0,,,,430802000.0,-328942000.0,,,,,,,29153000.0,6210000.0,2413000.0,2477000.0,3727000.0,5293000.0,9033000.0,4500000.0,,8793000.0,3407000.0,-10110000.0,-3490000.0,-6585000.0,35000.0,5119000.0,,,6530000.0,,,,,,,230487000.0,,142804000.0,,,,,2793000.0,,,,0.001,25000000.0,,0.0,29161000.0,,,,9251000.0,273632000.0,,,,157934000.0,,,7800000.0,-302139000.0,32828000.0,21837000.0,,4944000.0,231644000.0,,461000.0,2092000.0,461000.0,2092000.0,-832672000.0,5026000.0,,,,2890000.0,2612000.0,99909000.0,68014000.0,,,,,,2709510.0,53.53,20400000.0,520349.0,1328860.0,44.2,37687000.0,5399410.0,62.75,34558000.0,37528000.0,5216110.0,62.5,16.25,78.7,71.99,,,,49100000.0,,134005000.0,,5000.0,383454000.0,,478470.0,,,,,,28377000.0,,0.0,0.0,9338000.0,5534000.0,91900000.0,,,,42453135.0,,,,,,,
2018-03-31,2018-05-08,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,7569000.0,3671000.0,239000.0,49291000.0,,-631000.0,-315000.0,-946000.0,1526972000.0,,,18797000.0,,18797000.0,,5150737.0,817350000.0,581580000.0,,528831000.0,,631000.0,529462000.0,,,0.0,,,,,,226730000.0,,229203000.0,229203000.0,126162000.0,,,,,250000000.0,49665203.0,49665203.0,50000.0,34987000.0,,,,,,,837000.0,,,,,,225000.0,225000.0,,,,,,,723000.0,,,,,,,,,,,31166000.0,,,6160000.0,,,0.63,,0.62,,,,,,,,,,,,249000.0,249000.0,,16774000.0,,,,,,,,,,,,,,,,,,,,,,-4773000.0,,130000000.0,,44406000.0,,,30292000.0,,39000.0,,-1317000.0,-1501000.0,,-12583000.0,,,1311000.0,259000.0,,5253000.0,,,140752.0,137122000.0,,,260000.0,2068000.0,1808000.0,1737000.0,,,,,,,,,,,,,,93693000.0,817350000.0,57583000.0,,29907000.0,286419000.0,286419000.0,-71028000.0,-71028000.0,-89478000.0,-89478000.0,30253000.0,,,,107164000.0,-96487000.0,,,,,,,,,,,,,,,,7377000.0,1574000.0,-289000.0,-5272000.0,4734000.0,-249000.0,4944000.0,,,-4958000.0,,,,,,,260830000.0,,,,,,,475000.0,,,,,25000000.0,,0.0,33953000.0,270969000.0,,,3642000.0,60277000.0,,,,,,130000000.0,,30253000.0,,20830000.0,,,75504000.0,,542000.0,1931000.0,542000.0,1931000.0,-802419000.0,10677000.0,,,,1315000.0,10677000.0,31435000.0,18797000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,314616000.0,,,723657000.0,,,,,,,,,,,,,,,,,49077742.0,,,48190511.0,,,,,
2018-06-30,2018-08-03,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,10314000.0,17425000.0,,55735000.0,,-564000.0,-90000.0,-654000.0,1559722000.0,,,19563000.0,,19563000.0,,7894300.0,806022000.0,604743000.0,,540843000.0,1000.0,563000.0,541405000.0,,,,,,,,,110854000.0,,113328000.0,113328000.0,,,,,,250000000.0,50116056.0,50116056.0,50000.0,-52436000.0,,,,,,,,1244000.0,1244000.0,,,,141000.0,,,,,,,,,,,,,,,,,,,31166000.0,,,,,,-1.06,-1.06,-1.06,,,,,,,,,,,,,,,23479000.0,,,,,,,,,,,,,,,,,,,,,,,,40322000.0,,44406000.0,,,-52626000.0,,102000.0,,,,,,,,,,,,,,,132776000.0,,,462000.0,3342000.0,2880000.0,2448000.0,,,,,,,,,,,,,,102051000.0,806022000.0,66049000.0,,,,,,,,,-52728000.0,,,,107694000.0,-94900000.0,,,,,,,,,,,,,,,,8251000.0,3239000.0,225000.0,,292000.0,67000.0,4836000.0,,,-496000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,36844000.0,,,,,,,,,,,,,,,20858000.0,,,76835000.0,,652000.0,1822000.0,652000.0,1822000.0,-855147000.0,12794000.0,,,,,,30718000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,436278000.0,,,703971000.0,,,,,,,,,,,,,,,,,,49819528.0,,,,,,,
2018-09-30,2018-11-06,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,8198000.0,9155000.0,,58483000.0,,-381000.0,-29000.0,-410000.0,1605412000.0,,,20667000.0,,20667000.0,,7423974.0,765145000.0,567480000.0,,482870000.0,2000.0,383000.0,483251000.0,,,,,,,,,82956000.0,,,85430000.0,,,,,,250000000.0,50533070.0,50533070.0,51000.0,-87066000.0,,,,,,,1738000.0,,,,,,273000.0,,,,,,,,,,,,,,,,,,,31166000.0,,,,,,-1.74,-1.74,-1.74,,,,,,,,,,,,,,,29670000.0,,,,,,,,,,,,,,,,,,,,,,,,40300000.0,,44406000.0,,,-87063000.0,,247000.0,,,,,,,,,,,,,,,130232000.0,,,956000.0,5556000.0,4600000.0,2730000.0,,,,,,,,,,,,,,102549000.0,765145000.0,66681000.0,,,,,,,,,-87310000.0,,,,101409000.0,-89646000.0,,,,,,,,,,,,,,,,8450000.0,3199000.0,61000.0,,244000.0,183000.0,4702000.0,,,-147000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,49671000.0,,,,,,,,,,,,,,,19828000.0,,,70041000.0,,,,652000.0,1822000.0,-942457000.0,11763000.0,,,,,,31095000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,420142000.0,,,662596000.0,,,,,,,,,,,,,,,,,,50319772.0,,,,,,,
2018-12-31,2019-02-20,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,12275000.0,12740000.0,2641000.0,62450000.0,18206000.0,-304000.0,-329000.0,-633000.0,1639773000.0,,,81165000.0,,80107000.0,0.0,7454476.0,719558000.0,522369000.0,,434744000.0,2000.0,306000.0,435048000.0,,,0.0,,,1192000.0,,,113432000.0,,,115525000.0,12484000.0,,,,0.001,250000000.0,50860588.0,50860588.0,51000.0,-192564000.0,6852000.0,,,6790000.0,62000.0,,2979000.0,,,,,,1146000.0,,514000.0,,,31166000.0,,,,,361702000.0,31166000.0,,183331000.0,1189000.0,137019000.0,7418000.0,361702000.0,,31166000.0,,2900000.0,19538000.0,,,-1.73,-3.97,-1.73,-0.003,0.21,-0.268,,,-0.003,-0.008,-0.008,-0.002,,-0.095,-472000.0,,,36443000.0,1058000.0,,131000000.0,,,,,,,,,,,,,,,,,,,-5309000.0,500000.0,170322000.0,,44406000.0,0.0,-205440000.0,-197097000.0,8343000.0,514000.0,,3372000.0,7583000.0,,-1011000.0,,,5283000.0,377000.0,,14285000.0,,,,129223000.0,,,1681000.0,7065000.0,5384000.0,9542000.0,,434744000.0,6400000.0,,,,,,,,,,,110650000.0,719558000.0,74725000.0,,,336853000.0,,-33331000.0,,-290566000.0,,-285437000.0,,,,529469000.0,-371373000.0,,,,,,,27768000.0,5965000.0,2842000.0,2831000.0,3091000.0,4588000.0,8451000.0,6400000.0,,9095000.0,3514000.0,-303000.0,-5272000.0,5047000.0,78000.0,4759000.0,156000.0,,-5588000.0,,,,,,,509796000.0,509796000.0,,,,,,4076000.0,,,,0.001,25000000.0,,0.0,42858000.0,270969000.0,,,27828000.0,302564000.0,,,,7655000.0,7655000.0,170322000.0,25800000.0,-197611000.0,38252000.0,20046000.0,,,293998000.0,,,,271000.0,1822000.0,-1030283000.0,67756000.0,,,,,,127724000.0,,,,,,,2870804.0,62.1,22900000.0,812474.0,1479451.0,33.32,23243000.0,5353124.0,62.46,22555000.0,23191000.0,5134594.0,62.53,36.21,74.8,55.54,,,,51700000.0,,346274000.0,,14000.0,608908000.0,,713263.0,,,,,3700000.0,33727000.0,,0.0,0.0,4750000.0,600000.0,57500000.0,,,,49775223.0,,,,,,,
2019-03-31,2019-05-07,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,12664000.0,15628000.0,839000.0,48957000.0,,52000.0,-200000.0,-148000.0,2013859000.0,,,20475000.0,,20221000.0,,7618311.0,1007759000.0,786887000.0,,700012000.0,95000.0,43000.0,699960000.0,,,0.0,,,,22984000.0,,269712000.0,,,271976000.0,156451000.0,,,,,250000000.0,57303888.0,57303888.0,57000.0,-96271000.0,,,,,,,,,69000.0,,,,452000.0,,,,,,,,,,,,,,,,,,,31166000.0,,,2119000.0,,,-1.82,-1.82,-1.82,,,,,,,,,,,,-198000.0,,,20553000.0,,,,,,,,,,,,,,,,,,,,,,-589000.0,,,,44406000.0,,,-96540000.0,,216000.0,,-151000.0,2899000.0,,-12930000.0,,,3647000.0,-945000.0,,1414000.0,,,,129086000.0,,,2187000.0,10948000.0,8761000.0,3086000.0,,,,2672000.0,35677000.0,8451000.0,,4977000.0,4948000.0,5152000.0,6723000.0,5426000.0,7434000.0,121030000.0,1007759000.0,66880000.0,,,353617000.0,,-101193000.0,,-95775000.0,,-96756000.0,,,,117386000.0,-99214000.0,1957000.0,28243000.0,5259000.0,22984000.0,2000000.0,23024000.0,,,,,,,,,0.077,9556000.0,2660000.0,129000.0,,485000.0,356000.0,,,,-412000.0,,,,,,,260734000.0,,,,,,,3059000.0,,,,,25000000.0,,0.0,44995000.0,330415000.0,,,3897000.0,140000000.0,,,,22600000.0,,,,-96756000.0,,21696000.0,,,78105000.0,,,,351000.0,1913000.0,-1127039000.0,18172000.0,8280000.0,,,,,38829000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,445604000.0,63000.0,,886729000.0,,,,,,,,,,,,,,,652000.0,,53209215.0,53209215.0,,53209215.0,,,,,
2019-06-30,2019-08-02,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,8743000.0,20901000.0,,59264000.0,,429000.0,-174000.0,255000.0,2045685000.0,,,22490000.0,,22207000.0,,8378290.0,958927000.0,699431000.0,,604339000.0,429000.0,,603910000.0,,,0.0,,,,32968000.0,,131337000.0,,,133997000.0,,,,,,250000000.0,57665375.0,57665375.0,58000.0,-98769000.0,,,,,,,,,55000.0,,,,766000.0,,,,,,,,,,,,,,,,,,,31166000.0,,,,,,-1.72,-1.72,-1.72,,,,,,,,,,,,,,,28998000.0,,,,24167000.0,9828000.0,,,,,,,,,,,,,,,,,,,,,44406000.0,,,-98959000.0,,213000.0,,,,,,,,,,,,,,,129069000.0,,,2568000.0,13632000.0,11064000.0,4063000.0,,628506000.0,,3042000.0,50051000.0,13153000.0,,7541000.0,7433000.0,7561000.0,9639000.0,4724000.0,10084000.0,139140000.0,958927000.0,75006000.0,,,,,,,,,-99172000.0,,,,136623000.0,-112474000.0,2373000.0,39967000.0,6999000.0,32968000.0,2200000.0,33356000.0,,,,,,,,,0.075,11334000.0,3181000.0,26000.0,,403000.0,377000.0,,,,-376000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,46612000.0,,,,,,,,,,,,,,,25317000.0,,,96045000.0,,,,161000.0,2499000.0,-1226211000.0,24149000.0,,,,,,39812000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,486949000.0,,,819787000.0,,,,,,,,,,,,,,,669000.0,,57519308.0,57519308.0,,57519308.0,,,,,
2019-09-30,2019-11-06,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,13460000.0,23121000.0,,69557000.0,,337000.0,-408000.0,-71000.0,2066483000.0,,,19894000.0,,19907000.0,,8338200.0,879944000.0,613486000.0,,502880000.0,338000.0,1000.0,502543000.0,,,0.0,,,,31206000.0,,122577000.0,,,125237000.0,,,,,,250000000.0,57749890.0,57749890.0,58000.0,-113320000.0,,,,,,,,,16000.0,,,,,,,,,,,,,,,,,,,,,,,31166000.0,,,,,,,-1.96,,,,,,,,,,,,,,,,34681000.0,,,,26333000.0,2166000.0,,,,,,,,,,,,,,,,,,,,,44406000.0,,,-112701000.0,,293000.0,,,,,,,,,,,,,,,129020000.0,,,3385000.0,14138000.0,10753000.0,3319000.0,,529213000.0,,3041000.0,47847000.0,13153000.0,,7541000.0,7433000.0,7561000.0,9639000.0,2520000.0,9351000.0,152679000.0,879944000.0,90307000.0,,,,,,,,,-112994000.0,,,,143833000.0,-118033000.0,2411000.0,38496000.0,7290000.0,31206000.0,2200000.0,31711000.0,,,,,,,,,0.075,16904000.0,3111000.0,-234000.0,,-326000.0,-92000.0,,,,-153000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,49169000.0,,,,,,,,,,,,,,,31877000.0,,,100144000.0,,,,161000.0,2499000.0,-1339205000.0,25800000.0,,,,,,41006000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,404481000.0,,,727265000.0,,,,,,,,,,,,,,,630000.0,,,57707694.0,,,,,,,
2019-12-31,2020-02-14,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,12871000.0,32844000.0,6214000.0,83194000.0,25988000.0,159000.0,-306000.0,-147000.0,2086863000.0,,,82025000.0,,81995000.0,0.0,8132319.0,1135496000.0,851017000.0,,741168000.0,172000.0,13000.0,741009000.0,321646000.0,5174000.0,0.0,,,10367000.0,,,433584000.0,,,436244000.0,320719000.0,,,,0.001,250000000.0,57838220.0,57838220.0,58000.0,-402241000.0,8315000.0,,,7854000.0,461000.0,,,,,,,,,,1143000.0,,2140000.0,40968000.0,33306000.0,,,2140000.0,494458000.0,33306000.0,7662000.0,185892000.0,4183000.0,158791000.0,19622000.0,486796000.0,33306000.0,33306000.0,,3600000.0,8539000.0,,,,-8.74,,-0.008,0.21,-0.236,,,-0.003,-0.004,-0.01,-0.002,-0.005,-0.052,-165000.0,,,41324000.0,1206000.0,,133000000.0,,14832000.0,,,,,,,,,,,,,,,,,-688000.0,1092000.0,,,44406000.0,0.0,-399709000.0,-399444000.0,265000.0,3283000.0,,,20104000.0,,,2100000.0,2140000.0,4451000.0,,,8216000.0,,,,129000000.0,,,3355000.0,11546000.0,8191000.0,13238000.0,,768920000.0,,11942000.0,45668000.0,7582000.0,9786000.0,5571000.0,7541000.0,7521000.0,7667000.0,,8676000.0,481732000.0,1135496000.0,103300000.0,,5174000.0,679306000.0,,-13039000.0,,-345383000.0,,-496532000.0,,,,657932000.0,-424173000.0,9163000.0,36992000.0,7235000.0,29757000.0,9000000.0,30328000.0,,,,,,,,,0.075,18976000.0,3471000.0,23000.0,,486000.0,463000.0,,-2621000.0,,-787000.0,,,,,,,692824000.0,692824000.0,,14339000.0,,,,24832000.0,,,,0.001,25000000.0,,0.0,51397000.0,330415000.0,,,9829000.0,676238000.0,,,314234000.0,42718000.0,42718000.0,,7700000.0,-402727000.0,70336000.0,44348000.0,,,357355000.0,,,,161000.0,2499000.0,-1433010000.0,139307000.0,21861000.0,,,,,161524000.0,,,,,,,3429579.0,63.14,6500000.0,766457.0,1762075.0,37.15,18989000.0,6113064.0,62.51,,,5847778.0,62.58,32.87,72.48,63.03,,,,45300000.0,,321646000.0,,51000.0,653764000.0,,235678.0,,,,,2100000.0,39954000.0,,0.0,0.0,5575000.0,652000.0,125100000.0,2779000.0,,,56576885.0,,,,,,,
2020-03-31,2020-05-07,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,14405000.0,29327000.0,299000.0,67719000.0,,-1190000.0,-355000.0,-1545000.0,2162667000.0,,,20157000.0,,20172000.0,,8585289.0,1233140000.0,894318000.0,,663036000.0,583000.0,1773000.0,664226000.0,,,0.0,,,,,,298190000.0,,,300959000.0,-135285000.0,,,,,250000000.0,59488873.0,59488873.0,59000.0,-120423000.0,,,,,,,,,145283000.0,,,,,,,,,,,,,,,,,,,,,,,33306000.0,,,2852000.0,,,-2.05,-2.05,-2.05,,,,,,,,,,,,-623000.0,,,24572000.0,,,,,7668000.0,,,,,,,,,,,,,,33000.0,,,-474000.0,,,,44406000.0,,,-118616000.0,,409000.0,,,-3500000.0,125550000.0,,,,-149000.0,,,15096000.0,,,,129000000.0,,,3144000.0,11375000.0,8231000.0,2919000.0,,698456000.0,,,,,,,,,,,,623994000.0,1233140000.0,196858000.0,,41711000.0,55615000.0,,-95125000.0,,-95152000.0,,-119025000.0,,,,156974000.0,-120665000.0,,,7487000.0,34958000.0,,35827000.0,,,,,,,,,,13650000.0,4862000.0,-49000.0,,-1398000.0,-1349000.0,,-463000.0,,-456000.0,,,,,,,285229000.0,285229000.0,,,,,,14096000.0,,,,,25000000.0,,0.0,64788000.0,,,,380000.0,187600000.0,-33000.0,,,16600000.0,16600000.0,,,-119025000.0,,47596000.0,,,112961000.0,,,,161000.0,2608000.0,-1552035000.0,36309000.0,7397000.0,,,,,47516000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,365088000.0,,,609146000.0,,,,,,,,,,,,,,,,,,57995999.0,,,,,,,
2020-06-30,2020-07-30,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,9014000.0,14893000.0,,71887000.0,,1550000.0,-266000.0,1284000.0,2220963000.0,,,22428000.0,,22409000.0,,5214988.0,1314041000.0,906039000.0,,788848000.0,1562000.0,12000.0,787298000.0,,,0.0,,,,,,335639000.0,,,338407000.0,,,,,,250000000.0,60413756.0,60413756.0,60000.0,28144000.0,,,,,,,,,134898000.0,,,,,,,,,,33306000.0,,,,,,,,,,,,,,,,,,,0.42,,0.41,,,,,,,,,,,,,,,35836000.0,,,,,95200000.0,,,,,,,,,,,,,,,,,,,,,44406000.0,,,25730000.0,,415000.0,,,,,,,,,,,,,,,131275000.0,,,3384000.0,11061000.0,7677000.0,1797000.0,,929068000.0,,,,,,,,,,,,618454000.0,1314041000.0,219729000.0,,4068000.0,,,,,,,25315000.0,,,,124764000.0,-63055000.0,,,7258000.0,36308000.0,,37067000.0,,,,,,,,,,14332000.0,2627000.0,89000.0,,2829000.0,2740000.0,,,,217000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,58196000.0,,,,,,,,,,,,,,,48339000.0,,,80709000.0,,,,847000.0,1921000.0,-1526720000.0,61709000.0,,,,,,42252000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,477777000.0,,,695587000.0,,,,,,,,,,,,,,,,,61146231.0,,,59995617.0,,,,,
2020-09-30,2020-10-27,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,10850000.0,27762000.0,,79653000.0,,905000.0,108000.0,1013000.0,2260682000.0,,,20527000.0,,20341000.0,,8662701.0,1268385000.0,872003000.0,,746797000.0,912000.0,7000.0,745892000.0,,,0.0,,,,,,197486000.0,,,200254000.0,,,,,,250000000.0,60815690.0,60815690.0,61000.0,-69116000.0,,,,,,,,,102898000.0,,,,,,,,,,33306000.0,,,,,,,,,,,,,,,,,,,-1.13,-1.13,-1.13,,,,,,,,,,,,,,,43008000.0,,,,,-11520000.0,,,,,,,,,,,,,,,,,,,,,44406000.0,,,-68532000.0,,313000.0,,,,,,,,,,,,,,,131194000.0,,,4246000.0,14457000.0,10211000.0,1338000.0,,875497000.0,,,,,,,,,,,,602194000.0,1268385000.0,201186000.0,,,,,,,,,-68845000.0,,,,131785000.0,-50315000.0,,,7785000.0,36668000.0,,37597000.0,,,,,,,,,,16159000.0,5092000.0,374000.0,,-271000.0,-645000.0,,,,547000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,64264000.0,,,,,,,,,,,,,,,48773000.0,,,87314000.0,,,,847000.0,1921000.0,-1595565000.0,81470000.0,,,,,,42123000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,568034000.0,,,666191000.0,,,,,,,,,,,,,,,,,,60687177.0,,,,,,,
2020-12-31,2021-02-12,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,12923000.0,23093000.0,-848000.0,108491000.0,37392000.0,260000.0,429000.0,689000.0,2773195000.0,,,85833000.0,,85735000.0,0.0,8564311.0,1759555000.0,1295304000.0,,1172906000.0,277000.0,17000.0,1172646000.0,488007000.0,10506000.0,0.0,,,8515000.0,,,713526000.0,,,726294000.0,290050000.0,,,,0.001,250000000.0,66818520.0,66818520.0,67000.0,-185730000.0,,,,30408000.0,854000.0,,,,66568000.0,,,,,,1207000.0,,,66654000.0,33306000.0,,,,594487000.0,,33348000.0,222902000.0,28642000.0,184961000.0,24922000.0,561139000.0,33306000.0,,,4300000.0,12261000.0,,,-0.37,-3.07,-0.37,-0.007,0.21,-0.339,,0.022,-0.005,-0.009,0.009,-0.005,,-0.137,1119000.0,,,58176000.0,1304000.0,,155600000.0,,249458000.0,,,,,40000.0,1161000.0,460000.0,701000.0,1245000.0,513000.0,237000.0,495000.0,84000.0,,158000.0,0.0558,221000.0,1192000.0,,,44406000.0,0.0,-189449000.0,-185359000.0,4090000.0,1207000.0,,,-9840000.0,,,,,1346000.0,,,-2748000.0,,,,131113000.0,,,5864000.0,13048000.0,7184000.0,7038000.0,,1327662000.0,,13660000.0,55492000.0,3456000.0,11418000.0,6247000.0,10319000.0,12148000.0,11904000.0,,8426000.0,605180000.0,1759555000.0,189609000.0,,,600272000.0,,-179121000.0,,-132220000.0,,-210577000.0,,,,788769000.0,-330116000.0,10164000.0,47066000.0,8516000.0,38550000.0,10300000.0,40524000.0,,,,,,,,,0.067,24440000.0,8812000.0,735000.0,,836000.0,101000.0,7349000.0,-946000.0,,607000.0,,5555000.0,,,,,,813237000.0,,37062000.0,,,,43905000.0,,,,0.001,25000000.0,,0.0,57630000.0,435556000.0,,,89293000.0,589806000.0,-236000.0,,,,50990000.0,,88100000.0,-186566000.0,110907000.0,73515000.0,,,412084000.0,,,,10847000.0,1921000.0,-1619576000.0,362572000.0,,,,,,182933000.0,,,,,,,2989891.0,64.35,56900000.0,452081.0,1849106.0,35.22,453253000.0,6004603.0,62.99,221488000.0,430243000.0,5699638.0,62.99,58.51,69.38,62.51,,,,45400000.0,,,,15000.0,1154375000.0,,1505486.0,,,,,6300000.0,46662000.0,624000.0,0.0,0.0,6950000.0,382000.0,74300000.0,3298000.0,,,60845550.0,,,277000.0,17000.0,1172646000.0,1172906000.0,
2021-03-31,2021-05-05,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,15744000.0,25032000.0,-940000.0,82699000.0,,-88000.0,144000.0,56000.0,2810176000.0,,,24220000.0,,24298000.0,,8118221.0,1597763000.0,1070936000.0,,1016228000.0,68000.0,156000.0,1016316000.0,581614000.0,81624000.0,0.0,,,,,,383794000.0,,,396402000.0,-329892000.0,,,,,250000000.0,67439477.0,67439477.0,67000.0,-136774000.0,,,,,,,,,25089000.0,,,,,,,,,,33306000.0,,,,,,,,,,,,,,,,3367000.0,,,,-2.03,,,,,,,,,,,,,-771000.0,,,33850000.0,,,,,-20619000.0,,,,,,,,,,,,,,,,,,,,,44406000.0,,,-135762000.0,,379000.0,,,1993000.0,,,,,-474000.0,,,10656000.0,,,,131031000.0,,,5679000.0,12462000.0,6783000.0,639000.0,,1150365000.0,,,,,,,,,,,,543181000.0,1597763000.0,127044000.0,,,12649000.0,,-182424000.0,,-159346000.0,,-136141000.0,,,,205964000.0,-106569000.0,,,,,,38511000.0,,,,,,,,,,25393000.0,8929000.0,-285000.0,,-633000.0,-348000.0,,-325000.0,,-795000.0,,,,,,,,405230000.0,,,,,,16414000.0,,,,,25000000.0,,0.0,68034000.0,,,,12761000.0,224240000.0,-112000.0,,,,14980000.0,,,-136141000.0,,87570000.0,,,147518000.0,,,,10687000.0,1921000.0,-1755717000.0,99395000.0,,,,,,53258000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1054582000.0,,,,,,,,,,,,,,,,,,67102342.0,,,,,,,
2021-06-30,2021-08-03,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,21790000.0,24720000.0,,91060000.0,,-15000.0,247000.0,232000.0,2850016000.0,,,27099000.0,,27142000.0,,8500068.0,1512444000.0,949492000.0,,941373000.0,67000.0,82000.0,941388000.0,554881000.0,128031000.0,0.0,,,,,,290875000.0,,,302876000.0,,,,,,250000000.0,67764950.0,67764950.0,68000.0,-122252000.0,,,,,,,,,3912000.0,,,,,,,,,,33306000.0,,,,,,,,,,,,,,,,,,,-1.81,,-1.81,,,,,,,,,,,,,,,41545000.0,,,,,-31046000.0,,,,,,,,,,,,,,,,,,,,,44406000.0,,,-121965000.0,,463000.0,,,,,,,,,,,,,,,130950000.0,,,5626000.0,15083000.0,9457000.0,441000.0,,1044464000.0,,,,,,,,,,,,540273000.0,1512444000.0,127067000.0,,,,,,,,,-122428000.0,,,,169751000.0,-82776000.0,,,,,,38619000.0,,,,,,,,,,26964000.0,12668000.0,103000.0,,176000.0,73000.0,,,,-67000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,63933000.0,,,,,,,,,,,,,,,104568000.0,,,113205000.0,,,,10000000.0,2001000.0,-1878145000.0,86975000.0,,,,,,53410000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,972171000.0,,,,,,,,,,,,,,,,,67607752.0,,,67607752.0,,,,,
2021-09-30,2021-11-03,10-Q,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,15575000.0,25383000.0,,109660000.0,,-27000.0,81000.0,54000.0,2884695000.0,,,27005000.0,,26990000.0,,8317206.0,1484801000.0,846884000.0,,918632000.0,96000.0,123000.0,918659000.0,539579000.0,204243000.0,0.0,,,,,,197538000.0,,,209539000.0,,,,,,250000000.0,67961963.0,67961963.0,68000.0,-73176000.0,,,,,,,,,,,,,,,,,,,33306000.0,,,,,,,,,,,,,,,,,,,,-1.08,,,,,,,,,,,,,,,,55164000.0,,,,,25702000.0,,,,,,,,,,,,,,,,,,,,,44406000.0,,,-72816000.0,,182000.0,,,,,,,,,,,,,,,130869000.0,,,5645000.0,15191000.0,9546000.0,408000.0,,1004715000.0,,,,,,,,,,,,551127000.0,1484801000.0,135933000.0,,,,,,,,,-72998000.0,,,,,-89828000.0,,,,,,36696000.0,,,,,,,,,,32238000.0,16419000.0,-166000.0,,-178000.0,-12000.0,471000.0,,,-415000.0,,,,,,,,,,,,,,,,,,,25000000.0,,0.0,69193000.0,,,,,,,,,,,,,,,119069000.0,,,113417000.0,,,,10000000.0,2001000.0,-1951143000.0,81647000.0,,,,,,53883000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,933674000.0,,,,,,,,,,,,,,,,,,67875363.0,,,,,,,
2021-12-31,2022-02-15,10-K,Ultragenyx Pharmaceutical Inc.,RARE,CIK0001515673,USD,17138000.0,28432000.0,-6606000.0,145555000.0,50038000.0,-1283000.0,-121000.0,-1404000.0,2997497000.0,,,105260000.0,,104979000.0,0.0,8217574.0,1522397000.0,856604000.0,,,,,,432612000.0,258933000.0,,,,18993000.0,,,307584000.0,,,309585000.0,-416709000.0,,,,0.001,250000000.0,69344998.0,69344998.0,69000.0,-456118000.0,,,,,,,,,9076000.0,,,,,,1044000.0,,,42247000.0,33306000.0,,,,709610000.0,,8941000.0,306119000.0,13060000.0,218131000.0,25735000.0,700669000.0,33306000.0,,,5500000.0,13239000.0,,,,-6.7,,-0.002,0.21,-0.279,,,-0.001,-0.008,0.013,0.005,,-0.072,-1194000.0,,,62591000.0,1453000.0,,200000000.0,,-42063000.0,,,,,58000.0,978000.0,568000.0,410000.0,1030000.0,606000.0,75000.0,349000.0,52000.0,,310000.0,0.0544,,1058000.0,,,44406000.0,0.0,-455314000.0,-452981000.0,2333000.0,1044000.0,,,5432000.0,,,,,3117000.0,,,29508000.0,,,,130788000.0,,,5727000.0,16231000.0,10504000.0,1928000.0,,1001451000.0,,15719000.0,46741000.0,776000.0,12873000.0,2681000.0,6247000.0,11092000.0,13072000.0,,5749000.0,599836000.0,1522397000.0,181368000.0,,,118552000.0,,-195372000.0,,-338695000.0,,-454025000.0,,,1.0,,-381737000.0,11209000.0,40992000.0,10498000.0,30494000.0,11800000.0,34936000.0,,,,,,,,,0.0664,42084000.0,20558000.0,-550000.0,,-2093000.0,-1543000.0,1005000.0,-235000.0,,-1687000.0,,942000.0,,,,,,1012187000.0,,,,,,73093000.0,,,,0.001,25000000.0,,0.0,71745000.0,,,,40101000.0,718111000.0,-492000.0,,,,92896000.0,,36600000.0,,191285000.0,141247000.0,,,497153000.0,,,,,2001000.0,-2073601000.0,351406000.0,,,,,,219982000.0,,,,,,,3669577.0,64.93,38300000.0,336383.0,1217820.0,70.84,112242000.0,6198205.0,75.96,80283000.0,109665000.0,5951372.0,75.09,53.14,81.78,128.63,,,,48100000.0,,,,-14000.0,922561000.0,,687835.0,,,,,4100000.0,55360000.0,200000.0,0.0,0.0,8542000.0,356000.0,139500000.0,4142000.0,,,67795540.0,,,5000.0,1288000.0,969592000.0,968309000.0,3912000.0
